China will allow online sales of prescription drugs as early as this month, a policy that will open up an over 1 trillion yuan ($161 billion) market to online pharmacy operators like Alibaba Group Holding Ltd and Wal-Mart Stores Inc. The China Food and Drug Administration (CFDA) is finalising which prescription medicines to approve for sale, a senior healthcare policy adviser told Reuters. The policy would help reform a fragmented and opaque market controlled by state-run distributors and hospitals…
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”